Home
Analyst Insights
Company News
Markets
Top Picks

Biocryst Pharmaceuticals Inc

Biocryst Pharmaceuticals Inc (BCRX) EPS is poised to hit 0.04 next quarter: How Investors Can Make It Count the Most?

October 9, 2025

Steve Mayer

Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) open the trading on Wednesday, with great promise as it jumped 4.75% to $7.28, before ...

Most recent

Top Picks

No matter how cynical the overall market is Royal Gold, Inc (RGLD) performance over the last week is recorded 2.57%

Markets

Aveanna Healthcare Holdings Inc (AVAH) is heading in the right direction with an average volume of $1.28M

Company News

Deckers Outdoor Corp (DECK) recently have taken one step ahead with the beta value of 1.12

Analyst Insights

A Little Luck Can Go a Long Way with Cerus Corp (CERS) as it 5-day change was 10.53%

Top Picks

A Little Luck Can Go a Long Way with enGene Holdings Inc (ENGN) as it 5-day change was -2.50%

Markets

A Little Luck Can Go a Long Way with Mesoblast Ltd ADR (MESO) as it 5-day change was 21.39%

Newsdaemon.com is a business and stock news platform offering in-depth market coverage, aiming to expand readers’ understanding of public and private capital sharing through updates and detailed analysis.

Quick Links

About Us
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled